Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16109714rdf:typepubmed:Citationlld:pubmed
pubmed-article:16109714lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C0333516lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C1847321lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:16109714lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:16109714pubmed:issue42lld:pubmed
pubmed-article:16109714pubmed:dateCreated2005-10-17lld:pubmed
pubmed-article:16109714pubmed:abstractTextOsteoclast differentiation from hematopoietic precursors is controlled by the tumor necrosis factor family member tumor necrosis factor-related activation-induced cytokine (TRANCE) via induction of various transcription factors, including nuclear factor of activated T cells (NFAT) c1. During osteoclast differentiation, NFATc1 is further activated via calcium signaling when costimulatory receptors expressed on osteoclast precursors, such as osteoclast-associated receptor (OSCAR), are stimulated. Here we show that NFATc1 expression precedes that of OSCAR during TRANCE-mediated osteoclastogenesis and that inhibition of NFATc1 by cyclosporin A abolishes TRANCE-induced OSCAR expression and subsequent osteoclast differentiation. Moreover, we show that the 1.0-kb promoter region of the OSCAR gene contains three potential NFATc1-binding sites. Induction of an OSCAR promoter-luciferase reporter is significantly increased when transiently transfected into 293T cells in combination with NFATc1 expression plasmid. Deletion and site-directed mutant constructs confirmed that NFATc1-binding sites are both functional and NFATc1-specific. Furthermore, NFATc1 synergistically activates an OSCAR reporter construct together with microphthalmia transcription factor and PU.1, transcription factors previously shown to be critical for osteoclast differentiation. In addition, a plasmid expressing constitutively active MAP kinase kinase 6 enhances the transactivation activity of NFATc1/microphthalmia transcription factor/PU.1 on the OSCAR promoter. Taken together, our results indicate that NFATc1 is an important transcription factor in the induction of OSCAR during osteoclastogenesis. Elucidation of NFATc1 as a transcription factor for OSCAR expression implies the presence of a positive feedback circuit of TRANCE-induced activation of NFATc1, involving NFATc1-mediated OSCAR expression and its subsequent activation of NFATc1, necessary for efficient differentiation of osteoclasts.lld:pubmed
pubmed-article:16109714pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:languageenglld:pubmed
pubmed-article:16109714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:citationSubsetIMlld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16109714pubmed:statusMEDLINElld:pubmed
pubmed-article:16109714pubmed:monthOctlld:pubmed
pubmed-article:16109714pubmed:issn0021-9258lld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:TseLLlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:FisherDavid...lld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:ChoiYongwonYlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:KimKyung...lld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:KimNacksungNlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:KimJung HaJHlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:JinHye-MiHMlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:KimKabsunKlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:LeeJunwonJlld:pubmed
pubmed-article:16109714pubmed:authorpubmed-author:LeeSeoung-Hoo...lld:pubmed
pubmed-article:16109714pubmed:issnTypePrintlld:pubmed
pubmed-article:16109714pubmed:day21lld:pubmed
pubmed-article:16109714pubmed:volume280lld:pubmed
pubmed-article:16109714pubmed:ownerNLMlld:pubmed
pubmed-article:16109714pubmed:authorsCompleteYlld:pubmed
pubmed-article:16109714pubmed:pagination35209-16lld:pubmed
pubmed-article:16109714pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:meshHeadingpubmed-meshheading:16109714...lld:pubmed
pubmed-article:16109714pubmed:year2005lld:pubmed
pubmed-article:16109714pubmed:articleTitleNuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.lld:pubmed
pubmed-article:16109714pubmed:affiliationMedical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju, 501-746, Korea.lld:pubmed
pubmed-article:16109714pubmed:publicationTypeJournal Articlelld:pubmed
More...